Market News AIOpen the app

RCKT stock news · Rocket Pharmaceuticals, Inc.

Stories about Rocket Pharmaceuticals, Inc. (RCKT) from the last 90 days, each explained in plain English with whether the news reads good or bad for the company.

Get alerts for RCKT

Follow Rocket Pharmaceuticals, Inc. (RCKT) free. When we publish a story about it, you get the plain-English explanation as an alert.

Get alerts for RCKT
Free on the App Store and Google Play, or on the web.
  1. Oct 6, 2026, 5:40 PM ET · Market

    Rocket Pharmaceuticals, Inc. has signed a big loan deal for up to $150 million.

    Neutral

    Rocket Pharmaceuticals received $35 million under a loan and may seek more. The cash helps fund its work, but debt costs and claims on company assets leave its outlook balanced.

  2. Sep 15, 2026, 7:13 AM ET · Trial

    Rocket Pharmaceuticals, Inc. says it is working with the FDA on a key trial for RP-A501.

    Good for RCKT

    Rocket Pharmaceuticals announced FDA alignment on RP-A501 Phase 2 design, which I read as favorable for the program's ability to proceed.